nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfanilamide—CA9—hematologic cancer	0.324	1	CbGaD
Sulfanilamide—CA6—Imatinib—hematologic cancer	0.0467	0.0755	CbGbCtD
Sulfanilamide—CA6—Nilotinib—hematologic cancer	0.0424	0.0686	CbGbCtD
Sulfanilamide—CA7—Imatinib—hematologic cancer	0.0407	0.0658	CbGbCtD
Sulfanilamide—CA7—Nilotinib—hematologic cancer	0.037	0.0598	CbGbCtD
Sulfanilamide—CA12—Imatinib—hematologic cancer	0.0349	0.0565	CbGbCtD
Sulfanilamide—CA9—Imatinib—hematologic cancer	0.0349	0.0565	CbGbCtD
Sulfanilamide—CA12—Nilotinib—hematologic cancer	0.0317	0.0513	CbGbCtD
Sulfanilamide—CA9—Nilotinib—hematologic cancer	0.0317	0.0513	CbGbCtD
Sulfanilamide—CA2—Imatinib—hematologic cancer	0.0282	0.0457	CbGbCtD
Sulfanilamide—CA2—Nilotinib—hematologic cancer	0.0257	0.0415	CbGbCtD
Sulfanilamide—CYP2E1—Thalidomide—hematologic cancer	0.0114	0.0184	CbGbCtD
Sulfanilamide—CYP2C9—Bexarotene—hematologic cancer	0.0111	0.018	CbGbCtD
Sulfanilamide—CYP2E1—Dacarbazine—hematologic cancer	0.00978	0.0158	CbGbCtD
Sulfanilamide—CYP2D6—Lomustine—hematologic cancer	0.00944	0.0153	CbGbCtD
Sulfanilamide—CYP2C9—Idarubicin—hematologic cancer	0.0092	0.0149	CbGbCtD
Sulfanilamide—CYP2D6—Idarubicin—hematologic cancer	0.00841	0.0136	CbGbCtD
Sulfanilamide—CYP2C19—Bortezomib—hematologic cancer	0.00819	0.0132	CbGbCtD
Sulfanilamide—CYP2E1—Mitoxantrone—hematologic cancer	0.00759	0.0123	CbGbCtD
Sulfanilamide—CYP2D6—Hydroxyurea—hematologic cancer	0.00715	0.0116	CbGbCtD
Sulfanilamide—CYP2C19—Thalidomide—hematologic cancer	0.00713	0.0115	CbGbCtD
Sulfanilamide—CYP2C9—Bortezomib—hematologic cancer	0.00681	0.011	CbGbCtD
Sulfanilamide—CYP2C19—Teniposide—hematologic cancer	0.0068	0.011	CbGbCtD
Sulfanilamide—CYP3A4—Bexarotene—hematologic cancer	0.00646	0.0104	CbGbCtD
Sulfanilamide—CYP2C19—Ifosfamide—hematologic cancer	0.00628	0.0102	CbGbCtD
Sulfanilamide—CYP2D6—Bortezomib—hematologic cancer	0.00622	0.0101	CbGbCtD
Sulfanilamide—CYP3A4—Lomustine—hematologic cancer	0.006	0.00971	CbGbCtD
Sulfanilamide—CYP3A4—Busulfan—hematologic cancer	0.006	0.00971	CbGbCtD
Sulfanilamide—CYP2C19—Imatinib—hematologic cancer	0.006	0.0097	CbGbCtD
Sulfanilamide—CYP2C9—Thalidomide—hematologic cancer	0.00593	0.00959	CbGbCtD
Sulfanilamide—CYP2C9—Teniposide—hematologic cancer	0.00566	0.00915	CbGbCtD
Sulfanilamide—CYP3A4—Thiotepa—hematologic cancer	0.00535	0.00865	CbGbCtD
Sulfanilamide—CYP2C9—Ifosfamide—hematologic cancer	0.00522	0.00844	CbGbCtD
Sulfanilamide—CYP2C9—Imatinib—hematologic cancer	0.00499	0.00807	CbGbCtD
Sulfanilamide—CYP2E1—Etoposide—hematologic cancer	0.00479	0.00774	CbGbCtD
Sulfanilamide—CYP2D6—Imatinib—hematologic cancer	0.00456	0.00738	CbGbCtD
Sulfanilamide—CYP2C9—Nilotinib—hematologic cancer	0.00453	0.00733	CbGbCtD
Sulfanilamide—CYP3A4—Methoxsalen—hematologic cancer	0.00416	0.00673	CbGbCtD
Sulfanilamide—CYP2D6—Nilotinib—hematologic cancer	0.00414	0.0067	CbGbCtD
Sulfanilamide—CYP2D6—Vinorelbine—hematologic cancer	0.00411	0.00665	CbGbCtD
Sulfanilamide—CYP3A4—Bortezomib—hematologic cancer	0.00396	0.0064	CbGbCtD
Sulfanilamide—CYP2C19—Prednisone—hematologic cancer	0.00395	0.00639	CbGbCtD
Sulfanilamide—CYP2E1—Dexamethasone—hematologic cancer	0.00394	0.00637	CbGbCtD
Sulfanilamide—CYP3A4—Daunorubicin—hematologic cancer	0.00379	0.00612	CbGbCtD
Sulfanilamide—CYP3A4—Cytarabine—hematologic cancer	0.00334	0.0054	CbGbCtD
Sulfanilamide—CYP3A4—Teniposide—hematologic cancer	0.00329	0.00532	CbGbCtD
Sulfanilamide—CYP3A4—Ifosfamide—hematologic cancer	0.00304	0.00491	CbGbCtD
Sulfanilamide—CYP3A4—Imatinib—hematologic cancer	0.0029	0.00469	CbGbCtD
Sulfanilamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00273	0.00442	CbGbCtD
Sulfanilamide—CYP3A4—Nilotinib—hematologic cancer	0.00263	0.00426	CbGbCtD
Sulfanilamide—CYP3A4—Vinorelbine—hematologic cancer	0.00261	0.00423	CbGbCtD
Sulfanilamide—CYP2C9—Cisplatin—hematologic cancer	0.00254	0.00411	CbGbCtD
Sulfanilamide—CYP2D6—Vinblastine—hematologic cancer	0.00253	0.0041	CbGbCtD
Sulfanilamide—CYP2C19—Dexamethasone—hematologic cancer	0.00247	0.00399	CbGbCtD
Sulfanilamide—CYP3A4—Triamcinolone—hematologic cancer	0.00239	0.00387	CbGbCtD
Sulfanilamide—CYP3A4—Dasatinib—hematologic cancer	0.00233	0.00377	CbGbCtD
Sulfanilamide—CYP3A4—Mitoxantrone—hematologic cancer	0.0023	0.00372	CbGbCtD
Sulfanilamide—Burning sensation—Nelarabine—hematologic cancer	0.0021	0.119	CcSEcCtD
Sulfanilamide—CYP2C9—Dexamethasone—hematologic cancer	0.00205	0.00332	CbGbCtD
Sulfanilamide—CYP3A4—Betamethasone—hematologic cancer	0.00205	0.00332	CbGbCtD
Sulfanilamide—CYP3A4—Prednisolone—hematologic cancer	0.00202	0.00327	CbGbCtD
Sulfanilamide—CYP3A4—Prednisone—hematologic cancer	0.00191	0.00309	CbGbCtD
Sulfanilamide—Burning sensation—Idarubicin—hematologic cancer	0.00189	0.107	CcSEcCtD
Sulfanilamide—CYP2D6—Dexamethasone—hematologic cancer	0.00188	0.00303	CbGbCtD
Sulfanilamide—CYP3A4—Irinotecan—hematologic cancer	0.00181	0.00293	CbGbCtD
Sulfanilamide—CYP3A4—Vinblastine—hematologic cancer	0.00161	0.0026	CbGbCtD
Sulfanilamide—CYP3A4—Vincristine—hematologic cancer	0.00158	0.00256	CbGbCtD
Sulfanilamide—CYP2D6—Doxorubicin—hematologic cancer	0.00156	0.00252	CbGbCtD
Sulfanilamide—CYP3A4—Etoposide—hematologic cancer	0.00145	0.00235	CbGbCtD
Sulfanilamide—Burning sensation—Lenalidomide—hematologic cancer	0.0013	0.0731	CcSEcCtD
Sulfanilamide—CYP3A4—Dexamethasone—hematologic cancer	0.00119	0.00193	CbGbCtD
Sulfanilamide—Burning sensation—Thalidomide—hematologic cancer	0.00108	0.0607	CcSEcCtD
Sulfanilamide—Burning sensation—Carmustine—hematologic cancer	0.00103	0.0583	CcSEcCtD
Sulfanilamide—CYP3A4—Doxorubicin—hematologic cancer	0.000989	0.0016	CbGbCtD
Sulfanilamide—Mafenide—CA9—hematologic cancer	0.000746	0.395	CrCbGaD
Sulfanilamide—Discomfort—Methoxsalen—hematologic cancer	0.000524	0.0296	CcSEcCtD
Sulfanilamide—Discomfort—Daunorubicin—hematologic cancer	0.000502	0.0284	CcSEcCtD
Sulfanilamide—Discomfort—Anagrelide—hematologic cancer	0.0005	0.0282	CcSEcCtD
Sulfanilamide—Burning sensation—Methotrexate—hematologic cancer	0.000478	0.027	CcSEcCtD
Sulfanilamide—Burning sensation—Epirubicin—hematologic cancer	0.000448	0.0253	CcSEcCtD
Sulfanilamide—Burning sensation—Doxorubicin—hematologic cancer	0.000414	0.0234	CcSEcCtD
Sulfanilamide—Discomfort—Dasatinib—hematologic cancer	0.000413	0.0233	CcSEcCtD
Sulfanilamide—Discomfort—Bexarotene—hematologic cancer	0.000413	0.0233	CcSEcCtD
Sulfanilamide—Discomfort—Fludarabine—hematologic cancer	0.000412	0.0233	CcSEcCtD
Sulfanilamide—Discomfort—Nilotinib—hematologic cancer	0.000382	0.0216	CcSEcCtD
Sulfanilamide—Discomfort—Imatinib—hematologic cancer	0.00038	0.0214	CcSEcCtD
Sulfanilamide—Discomfort—Cladribine—hematologic cancer	0.000373	0.0211	CcSEcCtD
Sulfanilamide—Discomfort—Vinblastine—hematologic cancer	0.000358	0.0202	CcSEcCtD
Sulfanilamide—Discomfort—Lenalidomide—hematologic cancer	0.000331	0.0187	CcSEcCtD
Sulfanilamide—Discomfort—Hydroxyurea—hematologic cancer	0.000326	0.0184	CcSEcCtD
Sulfanilamide—Discomfort—Bortezomib—hematologic cancer	0.000305	0.0172	CcSEcCtD
Sulfanilamide—Discomfort—Bleomycin—hematologic cancer	0.000302	0.0171	CcSEcCtD
Sulfanilamide—Discomfort—Vinorelbine—hematologic cancer	0.000297	0.0168	CcSEcCtD
Sulfanilamide—Discomfort—Thalidomide—hematologic cancer	0.000275	0.0155	CcSEcCtD
Sulfanilamide—Discomfort—Alitretinoin—hematologic cancer	0.000261	0.0148	CcSEcCtD
Sulfanilamide—Discomfort—Ifosfamide—hematologic cancer	0.000258	0.0146	CcSEcCtD
Sulfanilamide—Discomfort—Irinotecan—hematologic cancer	0.000245	0.0138	CcSEcCtD
Sulfanilamide—Discomfort—Mitoxantrone—hematologic cancer	0.000245	0.0138	CcSEcCtD
Sulfanilamide—Aminohippurate—SLC22A1—hematologic cancer	0.000245	0.13	CrCbGaD
Sulfanilamide—Discomfort—Gemcitabine—hematologic cancer	0.000239	0.0135	CcSEcCtD
Sulfanilamide—Discomfort—Cisplatin—hematologic cancer	0.000223	0.0126	CcSEcCtD
Sulfanilamide—Discomfort—Etoposide—hematologic cancer	0.000204	0.0115	CcSEcCtD
Sulfanilamide—Discomfort—Prednisolone—hematologic cancer	0.000201	0.0114	CcSEcCtD
Sulfanilamide—Discomfort—Triamcinolone—hematologic cancer	0.000185	0.0104	CcSEcCtD
Sulfanilamide—Sulfamethazine—ALB—hematologic cancer	0.000178	0.0944	CrCbGaD
Sulfanilamide—Dapsone—MPO—hematologic cancer	0.000178	0.0941	CrCbGaD
Sulfanilamide—Sulfamerazine—ALB—hematologic cancer	0.000174	0.0923	CrCbGaD
Sulfanilamide—Discomfort—Dexamethasone—hematologic cancer	0.000168	0.00948	CcSEcCtD
Sulfanilamide—Discomfort—Betamethasone—hematologic cancer	0.000168	0.00948	CcSEcCtD
Sulfanilamide—Discomfort—Prednisone—hematologic cancer	0.000146	0.00825	CcSEcCtD
Sulfanilamide—Sulfamethizole—ALB—hematologic cancer	0.000135	0.0716	CrCbGaD
Sulfanilamide—Discomfort—Methotrexate—hematologic cancer	0.000122	0.0069	CcSEcCtD
Sulfanilamide—Discomfort—Epirubicin—hematologic cancer	0.000114	0.00646	CcSEcCtD
Sulfanilamide—Discomfort—Doxorubicin—hematologic cancer	0.000106	0.00597	CcSEcCtD
Sulfanilamide—Benzocaine—ABCB1—hematologic cancer	8.52e-05	0.0451	CrCbGaD
Sulfanilamide—Sulfamethoxazole—ALB—hematologic cancer	7.59e-05	0.0402	CrCbGaD
Sulfanilamide—Aminohippurate—ABCB1—hematologic cancer	7.13e-05	0.0377	CrCbGaD
Sulfanilamide—CYP3A4—Metabolism—DCK—hematologic cancer	6.96e-06	0.000181	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ASNS—hematologic cancer	6.96e-06	0.000181	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ALOX5—hematologic cancer	6.94e-06	0.00018	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—FHL2—hematologic cancer	6.93e-06	0.00018	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PIK3CD—hematologic cancer	6.92e-06	0.00018	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—AGRN—hematologic cancer	6.86e-06	0.000178	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—ALB—hematologic cancer	6.83e-06	0.000177	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—AGRN—hematologic cancer	6.8e-06	0.000177	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NUP98—hematologic cancer	6.73e-06	0.000175	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.67e-06	0.000173	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ARNTL—hematologic cancer	6.65e-06	0.000173	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—PIK3CA—hematologic cancer	6.6e-06	0.000171	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—HDC—hematologic cancer	6.6e-06	0.000171	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PIK3R1—hematologic cancer	6.54e-06	0.00017	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ADCY7—hematologic cancer	6.53e-06	0.00017	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NCOA3—hematologic cancer	6.53e-06	0.00017	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—IDH2—hematologic cancer	6.5e-06	0.000169	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—HMMR—hematologic cancer	6.5e-06	0.000169	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NUP214—hematologic cancer	6.48e-06	0.000168	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ACP5—hematologic cancer	6.47e-06	0.000168	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CA9—hematologic cancer	6.47e-06	0.000168	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—HMMR—hematologic cancer	6.45e-06	0.000167	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—IDH2—hematologic cancer	6.45e-06	0.000167	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NCOR2—hematologic cancer	6.38e-06	0.000166	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ABCG2—hematologic cancer	6.35e-06	0.000165	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—MTR—hematologic cancer	6.35e-06	0.000165	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ENO2—hematologic cancer	6.23e-06	0.000162	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—PTEN—hematologic cancer	6.19e-06	0.000161	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—PIK3CA—hematologic cancer	6.16e-06	0.00016	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ARNTL—hematologic cancer	6.11e-06	0.000159	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—IDH1—hematologic cancer	6.08e-06	0.000158	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.08e-06	0.000158	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ARNTL—hematologic cancer	6.06e-06	0.000157	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GSTT1—hematologic cancer	6.04e-06	0.000157	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CDA—hematologic cancer	6.03e-06	0.000157	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PIK3CB—hematologic cancer	6.03e-06	0.000157	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GSTO1—hematologic cancer	6.01e-06	0.000156	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—TXN—hematologic cancer	6.01e-06	0.000156	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ABCC3—hematologic cancer	6.01e-06	0.000156	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ACP5—hematologic cancer	5.95e-06	0.000154	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CA9—hematologic cancer	5.95e-06	0.000154	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—SDC1—hematologic cancer	5.9e-06	0.000153	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—EP300—hematologic cancer	5.9e-06	0.000153	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ACP5—hematologic cancer	5.9e-06	0.000153	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CA9—hematologic cancer	5.9e-06	0.000153	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—SPHK1—hematologic cancer	5.88e-06	0.000153	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NCOR2—hematologic cancer	5.87e-06	0.000152	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NCOR2—hematologic cancer	5.82e-06	0.000151	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PC—hematologic cancer	5.81e-06	0.000151	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—PIK3CA—hematologic cancer	5.71e-06	0.000148	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—UGT1A1—hematologic cancer	5.65e-06	0.000147	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.61e-06	0.000146	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GBA—hematologic cancer	5.61e-06	0.000146	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—IDH1—hematologic cancer	5.59e-06	0.000145	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—IDH1—hematologic cancer	5.54e-06	0.000144	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ABCC3—hematologic cancer	5.53e-06	0.000144	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—TXN—hematologic cancer	5.53e-06	0.000144	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GSTO1—hematologic cancer	5.53e-06	0.000144	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CRABP1—hematologic cancer	5.5e-06	0.000143	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—SLC22A1—hematologic cancer	5.5e-06	0.000143	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ABCC3—hematologic cancer	5.48e-06	0.000142	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GSTO1—hematologic cancer	5.48e-06	0.000142	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—TXN—hematologic cancer	5.48e-06	0.000142	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—SPHK1—hematologic cancer	5.41e-06	0.000141	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—AKT1—hematologic cancer	5.39e-06	0.00014	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—SPHK1—hematologic cancer	5.36e-06	0.000139	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ALOX5—hematologic cancer	5.36e-06	0.000139	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PTEN—hematologic cancer	5.21e-06	0.000135	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.2e-06	0.000135	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NUP98—hematologic cancer	5.19e-06	0.000135	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5.15e-06	0.000134	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—MTAP—hematologic cancer	5.13e-06	0.000133	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—SLC22A1—hematologic cancer	5.06e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CRABP1—hematologic cancer	5.06e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NCOA3—hematologic cancer	5.04e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ADCY7—hematologic cancer	5.04e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—AKT1—hematologic cancer	5.03e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NQO1—hematologic cancer	5.02e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CD44—hematologic cancer	5.02e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.01e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.01e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NUP214—hematologic cancer	5e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—EP300—hematologic cancer	4.97e-06	0.000129	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.95e-06	0.000129	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ALOX5—hematologic cancer	4.93e-06	0.000128	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.9e-06	0.000127	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—MTR—hematologic cancer	4.9e-06	0.000127	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ALOX5—hematologic cancer	4.89e-06	0.000127	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ENO2—hematologic cancer	4.81e-06	0.000125	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NUP98—hematologic cancer	4.77e-06	0.000124	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CYCS—hematologic cancer	4.75e-06	0.000123	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NUP98—hematologic cancer	4.73e-06	0.000123	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	4.72e-06	0.000123	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—AKT1—hematologic cancer	4.66e-06	0.000121	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.66e-06	0.000121	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.63e-06	0.00012	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.63e-06	0.00012	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NUP214—hematologic cancer	4.6e-06	0.000119	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.59e-06	0.000119	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.59e-06	0.000119	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.59e-06	0.000119	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—FHL2—hematologic cancer	4.57e-06	0.000119	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NUP214—hematologic cancer	4.56e-06	0.000118	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—SDC1—hematologic cancer	4.56e-06	0.000118	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.51e-06	0.000117	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—MTR—hematologic cancer	4.51e-06	0.000117	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.51e-06	0.000117	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—AGRN—hematologic cancer	4.48e-06	0.000116	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—MTR—hematologic cancer	4.47e-06	0.000116	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.47e-06	0.000116	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ENO2—hematologic cancer	4.42e-06	0.000115	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ENO2—hematologic cancer	4.38e-06	0.000114	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—PIK3CA—hematologic cancer	4.36e-06	0.000113	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.35e-06	0.000113	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.3e-06	0.000112	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.29e-06	0.000111	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—IDH2—hematologic cancer	4.25e-06	0.00011	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—HMMR—hematologic cancer	4.25e-06	0.00011	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.25e-06	0.00011	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—SDC1—hematologic cancer	4.19e-06	0.000109	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GSTP1—hematologic cancer	4.19e-06	0.000109	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.18e-06	0.000109	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—SDC1—hematologic cancer	4.15e-06	0.000108	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.11e-06	0.000107	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	4e-06	0.000104	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.97e-06	0.000103	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ABCB1—hematologic cancer	3.96e-06	0.000103	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.92e-06	0.000102	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CA9—hematologic cancer	3.89e-06	0.000101	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ACP5—hematologic cancer	3.89e-06	0.000101	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CD44—hematologic cancer	3.87e-06	0.000101	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NQO1—hematologic cancer	3.87e-06	0.000101	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NCOR1—hematologic cancer	3.85e-06	9.99e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GSTM1—hematologic cancer	3.85e-06	9.99e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.84e-06	9.97e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.79e-06	9.85e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.75e-06	9.73e-05	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PIK3CA—hematologic cancer	3.68e-06	9.55e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CYCS—hematologic cancer	3.67e-06	9.52e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—IDH1—hematologic cancer	3.66e-06	9.49e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.64e-06	9.46e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.61e-06	9.39e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—TXN—hematologic cancer	3.61e-06	9.39e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.61e-06	9.39e-05	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—AKT1—hematologic cancer	3.57e-06	9.26e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NQO1—hematologic cancer	3.56e-06	9.25e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CD44—hematologic cancer	3.56e-06	9.25e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.54e-06	9.19e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CD44—hematologic cancer	3.53e-06	9.17e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NQO1—hematologic cancer	3.53e-06	9.17e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.46e-06	8.98e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.4e-06	8.83e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.4e-06	8.83e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CYCS—hematologic cancer	3.37e-06	8.76e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.35e-06	8.7e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CYCS—hematologic cancer	3.34e-06	8.68e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.32e-06	8.62e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.31e-06	8.59e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.31e-06	8.59e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.28e-06	8.51e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.23e-06	8.39e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.22e-06	8.37e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.13e-06	8.12e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NUP98—hematologic cancer	3.12e-06	8.1e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.06e-06	7.94e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.03e-06	7.87e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.03e-06	7.87e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NUP214—hematologic cancer	3.01e-06	7.81e-05	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—AKT1—hematologic cancer	3e-06	7.8e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.99e-06	7.76e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.97e-06	7.72e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.97e-06	7.71e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.97e-06	7.71e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—MTR—hematologic cancer	2.95e-06	7.65e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.95e-06	7.65e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.95e-06	7.65e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ENO2—hematologic cancer	2.89e-06	7.51e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.86e-06	7.42e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.85e-06	7.4e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.81e-06	7.31e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.8e-06	7.28e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.79e-06	7.24e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—SDC1—hematologic cancer	2.74e-06	7.11e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.73e-06	7.09e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.73e-06	7.09e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.71e-06	7.03e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.71e-06	7.03e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.65e-06	6.88e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.62e-06	6.81e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.51e-06	6.52e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ALB—hematologic cancer	2.48e-06	6.44e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.41e-06	6.27e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.39e-06	6.21e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.37e-06	6.16e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NQO1—hematologic cancer	2.33e-06	6.05e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CD44—hematologic cancer	2.33e-06	6.05e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.31e-06	6.01e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.2e-06	5.73e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CYCS—hematologic cancer	2.2e-06	5.72e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.19e-06	5.69e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.19e-06	5.69e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.11e-06	5.48e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.04e-06	5.31e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.03e-06	5.27e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.01e-06	5.22e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.94e-06	5.05e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.94e-06	5.03e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ALB—hematologic cancer	1.91e-06	4.97e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PTEN—hematologic cancer	1.89e-06	4.91e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.88e-06	4.88e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.86e-06	4.84e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.84e-06	4.78e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.83e-06	4.75e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—EP300—hematologic cancer	1.8e-06	4.69e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.79e-06	4.64e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.79e-06	4.64e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.78e-06	4.63e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.77e-06	4.59e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ALB—hematologic cancer	1.76e-06	4.57e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ALB—hematologic cancer	1.74e-06	4.53e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.69e-06	4.39e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.68e-06	4.37e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.67e-06	4.33e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.58e-06	4.1e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.55e-06	4.04e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.54e-06	4e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PTEN—hematologic cancer	1.46e-06	3.79e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—EP300—hematologic cancer	1.39e-06	3.62e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PTEN—hematologic cancer	1.34e-06	3.49e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.33e-06	3.47e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PTEN—hematologic cancer	1.33e-06	3.46e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.33e-06	3.44e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—EP300—hematologic cancer	1.28e-06	3.33e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—EP300—hematologic cancer	1.27e-06	3.3e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.23e-06	3.19e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.17e-06	3.03e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ALB—hematologic cancer	1.15e-06	2.99e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.1e-06	2.86e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—AKT1—hematologic cancer	1.09e-06	2.83e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.03e-06	2.67e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.02e-06	2.64e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PIK3CA—hematologic cancer	9.47e-07	2.46e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.39e-07	2.44e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PTEN—hematologic cancer	8.78e-07	2.28e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—AKT1—hematologic cancer	8.41e-07	2.18e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—EP300—hematologic cancer	8.37e-07	2.17e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—AKT1—hematologic cancer	7.74e-07	2.01e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—AKT1—hematologic cancer	7.67e-07	1.99e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.19e-07	1.61e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—AKT1—hematologic cancer	5.06e-07	1.31e-05	CbGpPWpGaD
